Log in to your Inderes Free account to see all free content on this page.
Senzime
4.74 SEK
+1.83 %
Less than 1K followers
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Senzime
| Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.0 | 58.5 | 23.5 | 25.7 | 26.5 | 28.3 | 104.0 | 23.2 |
| EBITDA | -18.2 | -97.8 | -20.8 | -23.6 | -19.4 | -35.2 | -99.1 | -20.2 |
| EBIT | -28.0 | -124.1 | -26.9 | -29.3 | -25.4 | -41.0 | -122.6 | -25.9 |
| EBIT-% | -199.2 % | -212.1 % | -114.5 % | -114.0 % | -96.0 % | -144.5 % | -117.8 % | -111.4 % |
| Profit before taxes | -27.8 | -122.8 | -35.5 | -34.2 | -26.3 | -43.1 | -139.0 | -23.2 |
| Net income | -26.1 | -118.7 | -34.7 | -34.4 | -25.5 | -42.9 | -137.4 | -22.5 |
Login required
This content is only available for logged in users